Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Pang

Showing results (351-360 of 357) with videos related to

Pageof 36
Sort By:
You have reached the last page of results.This site can display upto 357 results.
Emerging Microbes & Infections|July 6, 2023
Wastewater surveillance monitoring of SARS-CoV-2 variants of concern and dynamics of transmission and community burden of COVID-19Maria E Hasing, Bonita E Lee, Tiejun Gao, et al.
Oncotarget|September 1, 2016
Phase Ib/II randomized, open-label study of doxorubicin and cyclophosphamide with or without low-dose, short-course sunitinib in the pre-operative treatment of breast cancerAndrea L A Wong, Raghav Sundar, Ting-Ting Wang, et al.
Leukemia|February 14, 2018
Oncogenic activation of JAK3-STAT signaling confers clinical sensitivity to PRN371, a novel selective and potent JAK3 inhibitor, in natural killer/T-cell lymphomaM -L Nairismägi, M E Gerritsen, Z M Li, et al.
Emerging Infectious Diseases|July 21, 2017
Global Spread of Norovirus GII.17 Kawasaki 308, 2014-2016Martin C W Chan, Yunwen Hu, Haili Chen, et al.
Annals of Surgical Oncology|September 7, 2022
Outcomes of a Phase II Study of Intraperitoneal Paclitaxel plus Systemic Capecitabine and Oxaliplatin (XELOX) for Gastric Cancer with Peritoneal MetastasesDaryl K A Chia, Raghav Sundar, Guowei Kim, et al.
Leukemia|February 9, 2016
JAK-STAT and G-protein-coupled receptor signaling pathways are frequently altered in epitheliotropic intestinal T-cell lymphomaM-L Nairismägi, J Tan, J Q Lim, et al.
Zhonghua Er Ke Za Zhi = Chinese Journal of Pediatrics|October 8, 2022
[A multicenter epidemiological study of acute bacterial meningitis in children]C Y Wang, H M Xu, J Tian, et al.
Pageof 36

Showing results (351-360 of 357) with videos related to

Sort By:
Pageof 36
You have reached the last page of results.This site can display upto 357 results.
Emerging Microbes & Infections|July 6, 2023
Wastewater surveillance monitoring of SARS-CoV-2 variants of concern and dynamics of transmission and community burden of COVID-19Maria E Hasing, Bonita E Lee, Tiejun Gao, et al.
Oncotarget|September 1, 2016
Phase Ib/II randomized, open-label study of doxorubicin and cyclophosphamide with or without low-dose, short-course sunitinib in the pre-operative treatment of breast cancerAndrea L A Wong, Raghav Sundar, Ting-Ting Wang, et al.
Leukemia|February 14, 2018
Oncogenic activation of JAK3-STAT signaling confers clinical sensitivity to PRN371, a novel selective and potent JAK3 inhibitor, in natural killer/T-cell lymphomaM -L Nairismägi, M E Gerritsen, Z M Li, et al.
Emerging Infectious Diseases|July 21, 2017
Global Spread of Norovirus GII.17 Kawasaki 308, 2014-2016Martin C W Chan, Yunwen Hu, Haili Chen, et al.
Annals of Surgical Oncology|September 7, 2022
Outcomes of a Phase II Study of Intraperitoneal Paclitaxel plus Systemic Capecitabine and Oxaliplatin (XELOX) for Gastric Cancer with Peritoneal MetastasesDaryl K A Chia, Raghav Sundar, Guowei Kim, et al.
Leukemia|February 9, 2016
JAK-STAT and G-protein-coupled receptor signaling pathways are frequently altered in epitheliotropic intestinal T-cell lymphomaM-L Nairismägi, J Tan, J Q Lim, et al.
Zhonghua Er Ke Za Zhi = Chinese Journal of Pediatrics|October 8, 2022
[A multicenter epidemiological study of acute bacterial meningitis in children]C Y Wang, H M Xu, J Tian, et al.
Pageof 36